Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
16.69
-0.99 (-5.60%)
At close: Oct 7, 2025, 4:00 PM EDT
17.14
+0.45 (2.70%)
Pre-market: Oct 8, 2025, 8:00 AM EDT
COEP Market Cap
COEP has a market cap or net worth of $80.45 million as of October 8, 2025. Its market cap has increased by 1,025.29% in one year.
Market Cap
80.45M
Enterprise Value
78.80M
1-Year Change
1,025.29%
Ranking
Category
Stock Price
$16.69
Market Cap Chart
Since December 17, 2020, COEP's market cap has decreased from $328.44M to $80.45M, a decrease of -75.51%. That is a compound annual growth rate of -25.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 80.45M | 611.48% |
| Dec 31, 2024 | 11.31M | -57.71% |
| Dec 29, 2023 | 26.74M | -10.53% |
| Dec 30, 2022 | 29.89M | -98.80% |
| Dec 31, 2021 | 2.49B | 637.84% |
| Dec 31, 2020 | 338.06M | 2.93% |
| Dec 17, 2020 | 328.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |